Evaluation of Luminescent P450 Analysis for Directed Evolution of Human CYP4A11

  • Choi, Seunghye (Department of Biological Sciences, Konkuk University) ;
  • Han, Songhee (Department of Biological Sciences, Konkuk University) ;
  • Lee, Hwayoun (Department of Biological Sciences, Konkuk University) ;
  • Chun, Young-Jin (College of Pharmacy, Chung-Ang University) ;
  • Kim, Donghak (Department of Biological Sciences, Konkuk University)
  • Received : 2013.10.21
  • Accepted : 2013.11.13
  • Published : 2013.11.30


Cytochrome P450 4A11 (CYP4A11) is a fatty acid hydroxylase enzyme expressed in human liver. It catalyzes not only the hydroxylation of saturated and unsaturated fatty acids, but the conversion of arachidonic acid to 20-hydroxyeicosatetraenoic acid (20-HETE), a regulator of blood pressure. In this study, we performed a directed evolution analysis of CYP4A11 using the luminogenic assay system. A random mutant library of CYP4A11, in which mutations were made throughout the entire coding region, was screened with luciferase activity to detect the demethylation of luciferin-4A (2-[6-methoxyquinolin-2-yl]-4,5-dihydrothiazole-4-carboxylic acid) of CYP4A11 mutants in Escherichia coli. Consecutive rounds of random mutagenesis and screening yielded three improved CYP4A11 mutants, CP2600 (A24T/T263A), CP2601 (T263A), and CP2616 (A24T/T263A/V430E) with ~3-fold increase in whole cells and >10-fold increase in purified proteins on the luminescence assay. However, the steady state kinetic analysis for lauric acid hydroxylation showed the significant reductions in enzymatic activities in all three mutants. A mutant, CP2600, showed a 51% decrease in catalytic efficiency ($k_{cat}/K_m$) for lauric acid hydroxylation mainly due to an increase in $K_m$. CP2601 and CP2616 showed much greater reductions (>75%) in the catalytic efficiency due to both a decrease in $k_{cat}$ and an increase in Km. These decreased catalytic activities of CP2601 and CP2616 can be partially attributed to the changes in substrate affinities. These results suggest that the enzymatic activities of CYP4A11 mutants selected from directed evolution using a luminogenic P450 substrate may not demonstrate a direct correlation with the hydroxylation activities of lauric acid.



  1. Adas, F., Salaun, J. P., Berthou, F., Picart, D., Simon, B. and Amet, Y. (1999) Requirement for omega and (omega-1)-hydroxylations of fatty acids by human cytochromes P450 2E1 and 4A11. J. Lipid Res. 40, 1990-1997.
  2. Branchini, B. R., Hayward, M. M., Bamford, S., Brennan, P. M. and Lajiness, E. J. (1989) Naphthyl- and quinolylluciferin: green and red light emitting firefly luciferin analogues. Photochem. Photobiol. 49, 689-695.
  3. Cali, J. J., Ma, D., Sobol, M., Simpson, D. J., Frackman, S., Good, T. D., Daily, W. J. and Liu, D. (2006) Luminogenic cytochrome P450 assays. Expert Opin. Drug Metab. Toxicol. 2, 629-645.
  4. Gainer, J. V., Bellamine, A., Dawson, E. P., Womble, K. E., Grant, S. W., Wang, Y., Cupples, L. A., Guo, C. Y., Demissie, S., O'Donnell, C. J., Brown, N. J., Waterman, M. R. and Capdevila, J. H. (2005) Functional variant of CYP4A11 20-hydroxyeicosatetraenoic acid synthase is associated with essential hypertension. Circulation 111, 63-69.
  5. Guengerich, F. P. (2005) Human cytochrome P450 enzymes. In Cytochrome P450: Structure, Mechanism, and Biochemistry (P. R. Ortiz de Montellano, Ed.), pp. 377-551. Plenum Press, New York.
  6. Han, S., Eun, C.-Y., Han, J.-S., Chun, Y.-J., Kim, D.-H., Yun, C.-H. and Kim, D. (2009) Self-sufficient catalytic system of human cytochrome P450 4A11 and NADPH-P450 reductase. Biomol. Ther. 17, 156-161.
  7. He, X., Cryle, M. J., De Voss, J. J. and de Montellano, P. R. (2005) Calibration of the channel that determines the omega-hydroxylation regiospecificity of cytochrome P4504A1: catalytic oxidation of 12-halododecanoic acids. J. Biol. Chem. 280, 22697-22705.
  8. Kim, D. and Guengerich, F. P. (2004a) Enhancement of 7-methoxyresorufin O-demethylation activity of human cytochrome P450 1A2 by molecular breeding. Arch. Biochem. Biophys. 432, 102-108.
  9. Kim, D. and Guengerich, F. P. (2004b) Selection of human cytochrome P450 1A2 mutants with enhanced catalytic activity for heterocyclic amine N-hydroxylation. Biochemistry 43, 981-988.
  10. Kim, D., Wu, Z. L. and Guengerich, F. P. (2005) Analysis of coumarin 7-hydroxylation activity of cytochrome P450 2A6 using random mutagenesis. J. Biol. Chem. 280, 40319-40327.
  11. Lee, H., Park, H. G., Lim, Y. R., Lee, I. S., Kim, B. J., Seong, C. H., Chun, Y. J. and Kim, D. (2012) Functional expression and characterization of recombinant NADPH-P450 reductase from Malassezia globosa. J. Microbiol. Biotechnol. 22, 141-146.
  12. Lim, Y. R., Eun, C. Y., Park, H. G., Han, S., Han, J. S., Cho, K. S., Chun, Y. J. and Kim, D. (2010) Regioselective oxidation of lauric acid by CYP119, an orphan cytochrome P450 from Sulfolobus acidocaldarius. J. Microbiol. Biotechnol. 20, 574-578.
  13. Nakamura, K., Martin, M. V. and Guengerich, F. P. (2001) Random mutagenesis of human cytochrome p450 2A6 and screening with indole oxidation products. Arch. Biochem. Biophys. 395, 25-31.
  14. Okita, R. T. and Okita, J. R. (2001) Cytochrome P450 4A fatty acid omega hydroxylases. Curr. Drug Metab. 2, 265-281.
  15. Ortiz de Montellano, P. R. (2005) Cytochrome P450: Structure, Mechanism, and Biochemistry. Plenum Press, New York.
  16. Park, H. G., Lim, Y. R., Eun, C. Y., Han, S., Han, J. S., Cho, K. S., Chun, Y. J. and Kim, D. (2010) Candida albicans NADPH-P450 reductase: expression, purification, and characterization of recombinant protein. Biochem. Biophys. Res. Commun. 396, 534-538.
  17. Pylypenko, O. and Schlichting, I. (2004) Structural aspects of ligand binding to and electron transfer in bacterial and fungal P450s. Annu. Rev. Biochem. 73, 991-1018.
  18. Sobol, M., Ma, D. and Cali, J. J. (2008) Selective cytochrome P450 4A11 enzyme assay using a novel bioluminescent probe substrate. Promega. [Internet] Available from: pubhub/enotes/selective-cytochrome-p450-4a11-enzymeassay-using-a-novel-bioluminescent-probe-substrate/
  19. Yun, C.-H., Miller, G. P. and Guengerich, F. P. (2000) Rate-determining steps in phenacetin oxidations by human cytochrome P450 1A2 and selected mutants. Biochemistry 39, 11319-11329.

Cited by

  1. Expression and Characterization of Truncated Recombinant Human Cytochrome P450 2J2 vol.30, pp.1, 2014,
  2. Biochemical analysis of recombinant CYP4A11 allelic variant enzymes: W126R, K276T and S353G vol.31, pp.6, 2016,
  3. Directed-Evolution Analysis of Human Cytochrome P450 2A6 for Enhanced Enzymatic Catalysis vol.77, pp.22-24, 2014,
  4. Functional Significance of Cytochrome P450 1A2 Allelic Variants, P450 1A2*8, *15, and *16 (R456H, P42R, and R377Q) vol.23, pp.2, 2015,
  5. Structural Analysis of the Streptomyces avermitilis CYP107W1-Oligomycin A Complex and Role of the Tryptophan 178 Residue vol.39, pp.3, 2016,
  6. Structural insights into the binding of lauric acid to CYP107L2 from Streptomyces avermitilis vol.482, pp.4, 2017,
  7. Heterologous expression and characterization of CYP61A1 from dandruff-causing Malassezia globosa vol.114, 2015,
  8. Functional characterization of CYP107W1 from Streptomyces avermitilis and biosynthesis of macrolide oligomycin A vol.575, 2015,
  9. Enhanced Purification of Recombinant Rat NADPH-P450 Reductase by Using a Hexahistidine-Tag vol.27, pp.5, 2013,
  10. A Specific Probe Substrate for Evaluation of CYP4A11 Activity in Human Tissue Microsomes and a Highly Selective CYP4A11 Inhibitor: Luciferin-4A and Epalrestat vol.366, pp.3, 2018,
  11. Overcoming the Challenges of Enzyme Evolution To Adapt Phosphotriesterase for V-Agent Decontamination vol.58, pp.15, 2013,
  12. Substrate Analogues for the Enzyme-Catalyzed Detoxification of the Organophosphate Nerve Agents-Sarin, Soman, and Cyclosarin vol.60, pp.38, 2013,